The drug, acquired in Pfizer's $43 billion purchase of Seagen, did not outlast standard chemotherapy in a 703-patient study ...

The healthcare company is eyeing opportunities related to artificial intelligence, which it believes can enhance its ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The trial enrolled 703 participants who had previously received one or more lines of systemic therapy.